Safety and Efficacy Study of Sitaxentan Sodium (Thelinâ„¢) in Patients With Pulmonary Arterial Hypertension
Phase 3
Completed
- Conditions
- First Posted Date
- 2004-04-05
- Last Posted Date
- 2007-11-09
- Lead Sponsor
- Encysive Pharmaceuticals
- Target Recruit Count
- 240
- Registration Number
- NCT00080457
- Locations
- 🇺🇸
Encysive Pharmaceuticals, Houston, Texas, United States
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
Phase 4
Completed
- Conditions
- First Posted Date
- 2002-06-14
- Last Posted Date
- 2007-01-11
- Lead Sponsor
- Encysive Pharmaceuticals
- Target Recruit Count
- 24
- Registration Number
- NCT00039858
- Locations
- 🇺🇸
Children's Hospital of Orange County, Orange, California, United States
🇺🇸Mattel Children's Hospital at UCLA, Los Angeles, California, United States
🇺🇸Children's Hospital of Boston, Boston, Massachusetts, United States
© Copyright 2024. All Rights Reserved by MedPath